MedCrypt to make QuiO’s Smartinjector device platform more secure

The initial agreement will see MedCrypt providing software security for QuiO’s first two products – the Si One, used for specialty drugs, and Si Pen, for diabetes patients. The technology’s drug delivery sensors and ability to automatically send real-time dosing data will now be able to sync with MedCrypt’s software, monitoring device usage for suspicious behavior. Additionally, the integration allows for devices to properly sign and encrypt data communicated through QuiO’s cloud platform, known as ConnectedRx.